Product Images Adalimumab-ryvk
View Photos of Packaging, Labels & Appearance
- 1 - avt02 unbranded 1
- 1 - avt02 unbranded 10
- 1 - avt02 unbranded 11
- 1 - avt02 unbranded 12
- Figure H - avt02 unbranded 13
- Figure I - avt02 unbranded 14
- Figure J - avt02 unbranded 15
- Figure K & Figure L - avt02 unbranded 16
- Figure M - avt02 unbranded 17
- Figure N - avt02 unbranded 18
- 1 - avt02 unbranded 19
- 1 - avt02 unbranded 2
- 80 mg AI - avt02 unbranded 20
- 1 - avt02 unbranded 21
- 1 - avt02 unbranded 22
- Figure C - avt02 unbranded 23
- Figure D - avt02 unbranded 24
- 1 - avt02 unbranded 25
- 1 - avt02 unbranded 26
- 1 - avt02 unbranded 27
- Figure H - avt02 unbranded 28
- Figure I - avt02 unbranded 29
- 1 - avt02 unbranded 3
- Figure J - avt02 unbranded 30
- Figures K & L - avt02 unbranded 31
- Figure M - avt02 unbranded 32
- Figure N - avt02 unbranded 33
- 1 - avt02 unbranded 34
- PARTS PFS - avt02 unbranded 35
- A - avt02 unbranded 36
- B - avt02 unbranded 37
- C - avt02 unbranded 38
- D - avt02 unbranded 39
- 1 - avt02 unbranded 4
- E - avt02 unbranded 40
- F - avt02 unbranded 41
- G - avt02 unbranded 42
- H - avt02 unbranded 43
- I - avt02 unbranded 44
- J - avt02 unbranded 45
- K - avt02 unbranded 46
- L - avt02 unbranded 47
- Calendar - avt02 unbranded 48
- 80 mg AI carton - avt02 unbranded 49
- AI 40 mg - avt02 unbranded 5
- 1 - avt02 unbranded 50
- 2 - avt02 unbranded 51
- 3 - avt02 unbranded 52
- 4 - avt02 unbranded 53
- 1 - avt02 unbranded 6
- 1 - avt02 unbranded 7
- Figure C - avt02 unbranded 8
- Figure D - avt02 unbranded 9
Product Label Images
The following 53 images provide visual information about the product associated with Adalimumab-ryvk NDC 51759-360 by Teva Pharmaceuticals Usa, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
1 - avt02 unbranded 2

This text contains data regarding the ASAS 20 response comparing a placebo group with an adalimumab group over a period of weeks. The data includes the number of participants in each group (107 for placebo and 208 for adalimumab) and the time points measured in weeks. The ASAS 20 response is likely being evaluated for the effectiveness of adalimumab treatment.*
80 mg AI - avt02 unbranded 20

This text appears to describe a product or an object that may involve an inspection process on a gray body with orange components. It includes a "Needle" feature and mentions a "Window Grip Area" along with a "Sleeve." The details suggest that this text could be related to the specifications or components of a device, tool, or mechanical part.*
2 - avt02 unbranded 51

This is a product label for a medication called Simlandi, specifically for adalimumab. It is an injection pre-filled with 20 mg per 0.2 mL for subcutaneous use only. The package includes 2 single-dose pre-filled syringes. The product code is NOC 51759386.*
4 - avt02 unbranded 53

This text appears to be a description of a medication packaging for a product called Simlandi, which contains adalimumab. The medication is in the form of an injection with a strength of 80 mg/0.8 mL for subcutaneous use only. The packaging includes a single-dose prefilled syringe along with additional items like alcohol preps, a quick reference guide, instructions for use, a medication guide, and prescribing information. The recommended dosage information may also be available.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.